CN Stock MarketDetailed Quotes

600267 Zhejiang Hisun Pharmaceutical

Watchlist
  • 8.45
  • -0.04-0.47%
Market Closed Nov 15 15:00 CST
10.21BMarket Cap-497058P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-9.50%7.87B
-13.48%5.24B
-11.00%2.73B
-13.82%10.37B
-0.49%8.7B
5.64%6.06B
2.90%3.06B
-0.82%12.04B
-3.99%8.74B
-4.46%5.74B
Operating revenue
-9.50%7.87B
-13.48%5.24B
-11.00%2.73B
-13.82%10.37B
-0.49%8.7B
5.64%6.06B
2.90%3.06B
-0.82%12.04B
-3.99%8.74B
-4.46%5.74B
Other operating revenue
----
-20.06%102.82M
----
-34.32%215.53M
----
21.55%128.62M
----
40.19%328.14M
----
9.49%105.82M
Total operating cost
-9.75%7.32B
-11.80%4.91B
-7.20%2.58B
-9.96%10.13B
-0.61%8.11B
2.98%5.56B
0.15%2.78B
-2.06%11.26B
-5.36%8.17B
-3.87%5.4B
Operating cost
-9.31%4.63B
-10.23%3.18B
-4.91%1.74B
-11.57%6.19B
-0.96%5.11B
3.18%3.54B
1.33%1.83B
-2.61%7B
-4.77%5.16B
-3.28%3.43B
Operating tax surcharges
28.90%77.05M
33.08%43.92M
13.23%26.91M
-20.83%84.94M
-17.85%59.77M
-26.59%33M
-21.72%23.77M
-0.49%107.3M
-14.65%72.76M
-11.86%44.96M
Operating expense
-12.26%1.58B
-19.14%999.87M
-14.21%470.41M
-1.57%2.37B
4.82%1.8B
10.80%1.24B
2.01%548.32M
-3.68%2.41B
-8.74%1.72B
-8.97%1.12B
Administration expense
-2.35%667.22M
-1.17%434.58M
-4.34%212.74M
-13.64%908.67M
-6.67%683.26M
-9.88%439.72M
-7.93%222.39M
5.62%1.05B
2.94%732.08M
8.77%487.91M
Financial expense
-31.83%101.4M
-29.21%72.53M
-32.11%37.95M
-27.05%191.67M
-23.99%148.74M
-26.90%102.46M
-24.90%55.89M
-20.68%262.75M
-26.29%195.69M
-24.59%140.16M
-Interest expense (Financial expense)
-26.01%123.27M
-23.57%87.51M
-17.17%46.82M
-23.92%215.4M
-24.05%166.6M
-26.03%114.5M
-26.69%56.52M
-18.13%283.12M
-18.35%219.37M
-17.26%154.8M
-Interest Income (Financial expense)
-18.15%-20.27M
-39.49%-15.03M
-93.27%-9.68M
12.60%-23.17M
9.85%-17.15M
13.67%-10.78M
-39.11%-5.01M
-22.22%-26.51M
-30.61%-19.03M
-18.73%-12.48M
Research and development
-15.65%262.63M
-15.74%177.55M
-8.10%89.18M
-8.57%391.95M
8.72%311.38M
16.13%210.71M
16.52%97.04M
14.99%428.69M
8.30%286.4M
13.01%181.44M
Credit Impairment Loss
32.45%-15.11M
33.06%-20.32M
88.80%-2.2M
-346.47%-23.48M
47.00%-22.37M
-131.09%-30.36M
-256.14%-19.64M
175.02%9.53M
-19.37%-42.2M
-3.25%-13.14M
Asset Impairment Loss
-123.19%-186.77M
14.05%-72.74M
-81.34%-32.27M
-126.54%-285.52M
-28.15%-83.68M
-176.00%-84.63M
38.68%-17.8M
-15.17%-126.04M
14.91%-65.3M
51.62%-30.66M
Other net revenue
115.92%55.47M
320.26%152.08M
1,099.15%124.28M
-51.41%-149.21M
129.20%25.69M
-52.70%36.19M
147.68%10.36M
-275.90%-98.55M
-158.93%-87.98M
2,323.57%76.5M
Fair value change income
-1,045.71%-13.23M
-171.36%-116.84K
-101.41%-21.81K
100.26%278.29K
103.76%1.4M
114.49%163.74K
148.52%1.55M
-503.96%-107.32M
-3,171.53%-37.21M
-237.44%-1.13M
Invest income
152.07%181.06M
72.91%170.21M
1,511.26%122.62M
163.53%66.06M
422.42%71.83M
49.45%98.44M
204.44%7.61M
-74.87%25.07M
-114.12%-22.28M
980.88%65.87M
-Including: Investment income associates
176.08%32.63M
211.32%19.55M
184.38%13.39M
61.68%-60.37M
26.24%-42.89M
1.10%-17.56M
-97.22%-15.87M
-108.01%-157.55M
-163.05%-58.15M
-1,765.89%-17.76M
Asset deal income
111.71%1.74M
324.21%2.68M
-100.05%-7.15K
-2,214.55%-11.49M
-2,840.68%-14.83M
-123.61%-1.2M
497.33%15.28M
97.59%-496.47K
-101.90%-504.44K
-67.43%5.07M
Other revenue
19.68%87.78M
34.58%72.37M
54.75%36.17M
4.20%104.95M
-7.77%73.34M
6.50%53.77M
38.20%23.37M
-13.76%100.71M
4.85%79.52M
-12.85%50.49M
Operating profit
-0.86%606.42M
-8.31%488.07M
-7.74%272.88M
-86.89%89.44M
24.61%611.66M
29.69%532.29M
62.86%295.76M
-2.51%682.48M
-21.97%490.84M
6.10%410.42M
Add:Non operating Income
557.04%6.33M
171.68%2.25M
424.68%263.4K
-79.68%1.72M
-80.15%962.83K
-78.53%828.94K
-98.33%50.2K
-59.01%8.47M
-71.31%4.85M
-28.79%3.86M
Less:Non operating expense
-85.31%7.23M
-90.00%4.76M
1,436.31%2.56M
2,211.81%174.03M
509.23%49.23M
652.58%47.58M
-78.99%166.33K
-90.17%7.53M
-9.49%8.08M
33.53%6.32M
Total profit
7.48%605.52M
0.01%485.56M
-8.48%270.59M
-112.13%-82.87M
15.54%563.39M
19.01%485.53M
60.84%295.65M
6.09%683.42M
-23.46%487.61M
5.27%407.96M
Less:Income tax cost
-9.46%95.24M
-26.06%51.53M
-55.21%24.24M
-92.64%14.15M
-29.57%105.19M
-21.33%69.7M
13.10%54.11M
43.90%192.19M
86.79%149.36M
84.92%88.59M
Net profit
11.37%510.29M
4.38%434.03M
1.99%246.35M
SL-97.01M
35.46%458.2M
30.21%415.83M
77.63%241.53M
-3.80%491.23M
-39.28%338.25M
-5.96%319.37M
Net profit from continuing operation
11.37%510.29M
4.38%434.03M
1.99%246.35M
-119.75%-97.01M
35.46%458.2M
30.21%415.83M
77.63%241.53M
-3.80%491.23M
-39.28%338.25M
-5.96%319.37M
Less:Minority Profit
-131.79%-5.03M
-110.36%-1.21M
-123.62%-2.18M
-261.88%-3.84M
123.20%15.82M
3,141.79%11.7M
996.00%9.23M
-90.00%2.37M
-87.70%7.09M
-99.39%360.77K
Net profit of parent company owners
16.49%515.31M
7.70%435.24M
6.99%248.53M
-119.06%-93.17M
33.58%442.38M
26.69%404.14M
71.91%232.3M
0.40%488.86M
-33.70%331.16M
13.88%319.01M
Earning per share
Basic earning per share
15.79%0.44
5.71%0.37
10.53%0.21
-119.05%-0.08
35.71%0.38
29.63%0.35
72.73%0.19
-2.33%0.42
-36.79%0.28
6.30%0.27
Diluted earning per share
15.79%0.44
15.63%0.37
23.53%0.21
-119.05%-0.08
35.71%0.38
23.08%0.32
54.55%0.17
-2.33%0.42
-35.19%0.28
4.00%0.26
Other composite income
-124.64%-512.37K
-134.21%-1.08M
48.35%-717.31K
-87.62%1.31M
-83.61%2.08M
-50.38%3.17M
-952.74%-1.39M
422.99%10.59M
351.69%12.69M
61.92%6.38M
Other composite income of parent company owners
-124.64%-512.37K
-134.21%-1.08M
48.35%-717.31K
-87.62%1.31M
-83.61%2.08M
-50.38%3.17M
-952.74%-1.39M
422.99%10.59M
351.69%12.69M
61.92%6.38M
Total composite income
10.75%509.77M
3.33%432.95M
2.29%245.63M
-119.07%-95.7M
31.16%460.28M
28.63%419M
76.40%240.14M
-1.09%501.83M
-36.43%350.94M
-5.18%325.75M
Total composite income of parent company owners
15.83%514.8M
6.59%434.16M
7.32%247.81M
-118.39%-91.86M
29.26%444.46M
25.18%407.3M
70.68%230.91M
3.28%499.45M
-30.45%343.85M
14.54%325.39M
Total composite income of minority owners
-131.79%-5.03M
-110.36%-1.21M
-123.62%-2.18M
-261.88%-3.84M
123.20%15.82M
3,141.79%11.7M
996.00%9.23M
-90.00%2.37M
-87.70%7.09M
-99.39%360.77K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -9.50%7.87B-13.48%5.24B-11.00%2.73B-13.82%10.37B-0.49%8.7B5.64%6.06B2.90%3.06B-0.82%12.04B-3.99%8.74B-4.46%5.74B
Operating revenue -9.50%7.87B-13.48%5.24B-11.00%2.73B-13.82%10.37B-0.49%8.7B5.64%6.06B2.90%3.06B-0.82%12.04B-3.99%8.74B-4.46%5.74B
Other operating revenue -----20.06%102.82M-----34.32%215.53M----21.55%128.62M----40.19%328.14M----9.49%105.82M
Total operating cost -9.75%7.32B-11.80%4.91B-7.20%2.58B-9.96%10.13B-0.61%8.11B2.98%5.56B0.15%2.78B-2.06%11.26B-5.36%8.17B-3.87%5.4B
Operating cost -9.31%4.63B-10.23%3.18B-4.91%1.74B-11.57%6.19B-0.96%5.11B3.18%3.54B1.33%1.83B-2.61%7B-4.77%5.16B-3.28%3.43B
Operating tax surcharges 28.90%77.05M33.08%43.92M13.23%26.91M-20.83%84.94M-17.85%59.77M-26.59%33M-21.72%23.77M-0.49%107.3M-14.65%72.76M-11.86%44.96M
Operating expense -12.26%1.58B-19.14%999.87M-14.21%470.41M-1.57%2.37B4.82%1.8B10.80%1.24B2.01%548.32M-3.68%2.41B-8.74%1.72B-8.97%1.12B
Administration expense -2.35%667.22M-1.17%434.58M-4.34%212.74M-13.64%908.67M-6.67%683.26M-9.88%439.72M-7.93%222.39M5.62%1.05B2.94%732.08M8.77%487.91M
Financial expense -31.83%101.4M-29.21%72.53M-32.11%37.95M-27.05%191.67M-23.99%148.74M-26.90%102.46M-24.90%55.89M-20.68%262.75M-26.29%195.69M-24.59%140.16M
-Interest expense (Financial expense) -26.01%123.27M-23.57%87.51M-17.17%46.82M-23.92%215.4M-24.05%166.6M-26.03%114.5M-26.69%56.52M-18.13%283.12M-18.35%219.37M-17.26%154.8M
-Interest Income (Financial expense) -18.15%-20.27M-39.49%-15.03M-93.27%-9.68M12.60%-23.17M9.85%-17.15M13.67%-10.78M-39.11%-5.01M-22.22%-26.51M-30.61%-19.03M-18.73%-12.48M
Research and development -15.65%262.63M-15.74%177.55M-8.10%89.18M-8.57%391.95M8.72%311.38M16.13%210.71M16.52%97.04M14.99%428.69M8.30%286.4M13.01%181.44M
Credit Impairment Loss 32.45%-15.11M33.06%-20.32M88.80%-2.2M-346.47%-23.48M47.00%-22.37M-131.09%-30.36M-256.14%-19.64M175.02%9.53M-19.37%-42.2M-3.25%-13.14M
Asset Impairment Loss -123.19%-186.77M14.05%-72.74M-81.34%-32.27M-126.54%-285.52M-28.15%-83.68M-176.00%-84.63M38.68%-17.8M-15.17%-126.04M14.91%-65.3M51.62%-30.66M
Other net revenue 115.92%55.47M320.26%152.08M1,099.15%124.28M-51.41%-149.21M129.20%25.69M-52.70%36.19M147.68%10.36M-275.90%-98.55M-158.93%-87.98M2,323.57%76.5M
Fair value change income -1,045.71%-13.23M-171.36%-116.84K-101.41%-21.81K100.26%278.29K103.76%1.4M114.49%163.74K148.52%1.55M-503.96%-107.32M-3,171.53%-37.21M-237.44%-1.13M
Invest income 152.07%181.06M72.91%170.21M1,511.26%122.62M163.53%66.06M422.42%71.83M49.45%98.44M204.44%7.61M-74.87%25.07M-114.12%-22.28M980.88%65.87M
-Including: Investment income associates 176.08%32.63M211.32%19.55M184.38%13.39M61.68%-60.37M26.24%-42.89M1.10%-17.56M-97.22%-15.87M-108.01%-157.55M-163.05%-58.15M-1,765.89%-17.76M
Asset deal income 111.71%1.74M324.21%2.68M-100.05%-7.15K-2,214.55%-11.49M-2,840.68%-14.83M-123.61%-1.2M497.33%15.28M97.59%-496.47K-101.90%-504.44K-67.43%5.07M
Other revenue 19.68%87.78M34.58%72.37M54.75%36.17M4.20%104.95M-7.77%73.34M6.50%53.77M38.20%23.37M-13.76%100.71M4.85%79.52M-12.85%50.49M
Operating profit -0.86%606.42M-8.31%488.07M-7.74%272.88M-86.89%89.44M24.61%611.66M29.69%532.29M62.86%295.76M-2.51%682.48M-21.97%490.84M6.10%410.42M
Add:Non operating Income 557.04%6.33M171.68%2.25M424.68%263.4K-79.68%1.72M-80.15%962.83K-78.53%828.94K-98.33%50.2K-59.01%8.47M-71.31%4.85M-28.79%3.86M
Less:Non operating expense -85.31%7.23M-90.00%4.76M1,436.31%2.56M2,211.81%174.03M509.23%49.23M652.58%47.58M-78.99%166.33K-90.17%7.53M-9.49%8.08M33.53%6.32M
Total profit 7.48%605.52M0.01%485.56M-8.48%270.59M-112.13%-82.87M15.54%563.39M19.01%485.53M60.84%295.65M6.09%683.42M-23.46%487.61M5.27%407.96M
Less:Income tax cost -9.46%95.24M-26.06%51.53M-55.21%24.24M-92.64%14.15M-29.57%105.19M-21.33%69.7M13.10%54.11M43.90%192.19M86.79%149.36M84.92%88.59M
Net profit 11.37%510.29M4.38%434.03M1.99%246.35MSL-97.01M35.46%458.2M30.21%415.83M77.63%241.53M-3.80%491.23M-39.28%338.25M-5.96%319.37M
Net profit from continuing operation 11.37%510.29M4.38%434.03M1.99%246.35M-119.75%-97.01M35.46%458.2M30.21%415.83M77.63%241.53M-3.80%491.23M-39.28%338.25M-5.96%319.37M
Less:Minority Profit -131.79%-5.03M-110.36%-1.21M-123.62%-2.18M-261.88%-3.84M123.20%15.82M3,141.79%11.7M996.00%9.23M-90.00%2.37M-87.70%7.09M-99.39%360.77K
Net profit of parent company owners 16.49%515.31M7.70%435.24M6.99%248.53M-119.06%-93.17M33.58%442.38M26.69%404.14M71.91%232.3M0.40%488.86M-33.70%331.16M13.88%319.01M
Earning per share
Basic earning per share 15.79%0.445.71%0.3710.53%0.21-119.05%-0.0835.71%0.3829.63%0.3572.73%0.19-2.33%0.42-36.79%0.286.30%0.27
Diluted earning per share 15.79%0.4415.63%0.3723.53%0.21-119.05%-0.0835.71%0.3823.08%0.3254.55%0.17-2.33%0.42-35.19%0.284.00%0.26
Other composite income -124.64%-512.37K-134.21%-1.08M48.35%-717.31K-87.62%1.31M-83.61%2.08M-50.38%3.17M-952.74%-1.39M422.99%10.59M351.69%12.69M61.92%6.38M
Other composite income of parent company owners -124.64%-512.37K-134.21%-1.08M48.35%-717.31K-87.62%1.31M-83.61%2.08M-50.38%3.17M-952.74%-1.39M422.99%10.59M351.69%12.69M61.92%6.38M
Total composite income 10.75%509.77M3.33%432.95M2.29%245.63M-119.07%-95.7M31.16%460.28M28.63%419M76.40%240.14M-1.09%501.83M-36.43%350.94M-5.18%325.75M
Total composite income of parent company owners 15.83%514.8M6.59%434.16M7.32%247.81M-118.39%-91.86M29.26%444.46M25.18%407.3M70.68%230.91M3.28%499.45M-30.45%343.85M14.54%325.39M
Total composite income of minority owners -131.79%-5.03M-110.36%-1.21M-123.62%-2.18M-261.88%-3.84M123.20%15.82M3,141.79%11.7M996.00%9.23M-90.00%2.37M-87.70%7.09M-99.39%360.77K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion with explanatory notes------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data